Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Corticosteroids, Glucose Control, and Depth-of-Anesthesia on Perioperative Inflammation and Morbidity From Major Non-cardiac Surgery (Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT Trial))

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥40 years old.~2. Major non-cardiac surgical procedures scheduled to take ≥ two hours done under general anesthesia.~3. Written informed consent~Exclusion Criteria:~1. Recent intravenous or oral steroid therapy (within 30 days); inhaled steroids are permitted~2. Any contraindications to the proposed interventions~3. ASA Physical Status \> 4~4. Non English speaking patients~5. Procedures done under regional anesthesia

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Intensive Glucose Control, Dexamethasone, light anesthesia (Type: ACTIVE_COMPARATOR): * Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl~* Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Light anesthesia target BIS of 55
- Intensive Glucose Control, Dexamethasone, Deep anesthesia (Type: ACTIVE_COMPARATOR): * Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl~* Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Deep anesthesia target BIS of 35
- Intensive Glucose Control, placebo, Light anesthesia (Type: ACTIVE_COMPARATOR): * Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl~* Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Light anesthesia target BIS of 55
- Conventional Glucose Control, Dexamethasone, Light anesthesia (Type: ACTIVE_COMPARATOR): * Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl~* Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Light anesthesia target BIS of 55
- Intensive Glucose Control, Placebo, Deep anesthesia (Type: ACTIVE_COMPARATOR): * Intensive Glucose Control The target range for blood glucose will be 80-110 mg/dl~* Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Deep anesthesia target BIS of 35
- Conventional Glucose Control, Dexamethasone, Deep anesthesia (Type: ACTIVE_COMPARATOR): * Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl~* Dexamethasone Dexamethasone administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Deep anesthesia target BIS of 35
- Conventional Glucose Control, Placebo, Light anesthesia (Type: ACTIVE_COMPARATOR): * Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl~* Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Light anesthesia target BIS of 55
- Conventional Glucose Control, Placebo, Deep anesthesia (Type: PLACEBO_COMPARATOR): * Conventional Glucose Control The target range for blood glucose will be 180-200 mg/dl~* Placebo Placebo administered at 8 mg given 1-2 hours before surgery (incision time), 4 mg on the first postoperative morning, and 2 mg on the second postoperative morning.~* Deep anesthesia target BIS of 35

Based on this trial design, predict the completion outcome and termination type (if applicable).